2BB score and signals
Skye Bioscience, Inc.’s current 2BB score is 11 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 6 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 40 | Normal |
| Risk | 93 | Very High |
2BBBullish & Bearish
Skye Bioscience, Inc. (SKYE) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 11 out of 100.
Skye Bioscience, Inc.’s current 2BB score is 11 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 6 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 40 | Normal |
| Risk | 93 | Very High |
| Founded | 2011 |
| Employees | 2 |
| 52-week range | $1.50 – $13.28 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-08 | — | -1.5178 | — | $0.00 |
| 2026-11-09 | — | -1.6646 | — | $0.00 |
| 2026-08-05 | — | -0.2518 | — | $0.00 |
| 2026-05-11 | -0.32 | -0.3153 | $0.00 | $0.00 |